These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 38443130)

  • 21. Long-Term Effectiveness and Safety of Up to 48 Weeks' Treatment with Topical Adapalene 0.3%/Benzoyl Peroxide 2.5% Gel in the Prevention and Reduction of Atrophic Acne Scars in Moderate and Severe Facial Acne.
    Dréno B; Bissonnette R; Gagné-Henley A; Barankin B; Lynde C; Chavda R; Kerrouche N; Tan J
    Am J Clin Dermatol; 2019 Oct; 20(5):725-732. PubMed ID: 31209851
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Updates on Topical Dyad and Triple Combination Therapies Approved for Acne Vulgaris.
    Podwojniak A; Tan IJ; Sauer J; Parikh A; Cohen BA; Heath C
    Cureus; 2024 May; 16(5):e61413. PubMed ID: 38947674
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of 2 clindamycin 1%-benzoyl peroxide 5% topical gels used once daily in the management of acne vulgaris.
    Dhawan SS
    Cutis; 2009 May; 83(5):265-72. PubMed ID: 19537284
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sub-group Analyses from a Trial of a Fixed Combination of Clindamycin Phosphate 1.2% and Benzoyl Peroxide 3.75% Gel for the Treatment of Moderate-to-severe Acne Vulgaris.
    Gold MH; Korotzer A
    J Clin Aesthet Dermatol; 2015 Dec; 8(12):22-6. PubMed ID: 26705445
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tolerability and Efficacy of Clindamycin/Tretinoin versus Adapalene/Benzoyl Peroxide in the Treatment of Acne Vulgaris.
    Aschoff R; Möller S; Haase R; Kuske M
    J Drugs Dermatol; 2021 Mar; 20(3):295-301. PubMed ID: 33683070
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of acne with a combination clindamycin/benzoyl peroxide gel compared with clindamycin gel, benzoyl peroxide gel and vehicle gel: combined results of two double-blind investigations.
    Lookingbill DP; Chalker DK; Lindholm JS; Katz HI; Kempers SE; Huerter CJ; Swinehart JM; Schelling DJ; Klauda HC
    J Am Acad Dermatol; 1997 Oct; 37(4):590-5. PubMed ID: 9344199
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of Moderate Acne Vulgaris in Fitzpatrick Skin Type V or VI: Efficacy and Tolerability of Fixed Combination Clindamycin Phosphate 1.2%/Benzoyl Peroxide 3.75% Gel.
    Amar L; Kircik LH
    J Drugs Dermatol; 2018 Oct; 17(10):1107-1112. PubMed ID: 30365592
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clindamycin/benzoyl peroxide gel: a review of its use in the management of acne.
    Warner GT; Plosker GL
    Am J Clin Dermatol; 2002; 3(5):349-60. PubMed ID: 12069641
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An aqueous gel fixed combination of clindamycin phosphate 1.2% and benzoyl peroxide 3.75% for the once-daily treatment of moderate to severe acne vulgaris.
    Pariser DM; Rich P; Cook-Bolden FE; Korotzer A
    J Drugs Dermatol; 2014 Sep; 13(9):1083-9. PubMed ID: 25226009
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The tolerability profile of clindamycin 1%/benzoyl peroxide 5% gel vs. adapalene 0.1%/benzoyl peroxide 2.5% gel for facial acne: results of a randomized, single-blind, split-face study.
    Gonzalez P; Vila R; Cirigliano M
    J Cosmet Dermatol; 2012 Dec; 11(4):251-60. PubMed ID: 23174047
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of moderate to severe acne vulgaris in a Hispanic population: a post-hoc analysis of efficacy and tolerability of clindamycin phosphate 1.2%/benzoyl peroxide 2.5% gel.
    Cook-Bolden FE
    J Drugs Dermatol; 2012 Apr; 11(4):455-9. PubMed ID: 22453581
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adapalene-benzoyl peroxide, a unique fixed-dose combination topical gel for the treatment of acne vulgaris: a transatlantic, randomized, double-blind, controlled study in 1670 patients.
    Gollnick HP; Draelos Z; Glenn MJ; Rosoph LA; Kaszuba A; Cornelison R; Gore B; Liu Y; Graeber M;
    Br J Dermatol; 2009 Nov; 161(5):1180-9. PubMed ID: 19466959
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fixed Combination of Clindamycin Phosphate 1.2% and Benzoyl Peroxide 3.75% Aqueous Gel: Long-Term Use in Adult Females With Moderate Acne Vulgaris.
    Kircik LH
    J Drugs Dermatol; 2017 Jun; 16(6):543-546. PubMed ID: 28686771
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A multicentre, randomized, single-blind comparison of topical clindamycin 1%/benzoyl peroxide 5% once-daily gel versus clindamycin 1% twice-daily gel in the treatment of mild to moderate acne vulgaris in Chinese patients.
    Xu JH; Lu QJ; Huang JH; Hao F; Sun QN; Fang H; Gu J; Dong XQ; Zheng J; Luo D; Li FQ; Wang G; Gu H; Tian HQ; Yang HL; Xi LY; Li M; Zheng M; Wu Y; Tu YT; He YL; Zhao G; Sheng WX; Li J; Hamedani AG
    J Eur Acad Dermatol Venereol; 2016 Jul; 30(7):1176-82. PubMed ID: 27075705
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of the efficacy and safety of a combination topical gel formulation of benzoyl peroxide and clindamycin with benzoyl peroxide, clindamycin and vehicle gel in the treatments of acne vulgaris.
    Leyden JJ; Berger RS; Dunlap FE; Ellis CN; Connolly MA; Levy SF
    Am J Clin Dermatol; 2001; 2(1):33-9. PubMed ID: 11702619
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clindamycin phosphate 1·2%-benzoyl peroxide 3·0% fixed-dose combination gel has an effective and acceptable safety and tolerability profile for the treatment of acne vulgaris in Japanese patients: a phase III, multicentre, randomised, single-blinded, active-controlled, parallel-group study.
    Kawashima M; Hashimoto H; Alió Sáenz AB; Ono M; Yamada M
    Br J Dermatol; 2015 Feb; 172(2):494-503. PubMed ID: 25040180
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and tolerability of a fixed combination of clindamycin phosphate (1.2%) and low concentration benzoyl peroxide (2.5%) aqueous gel in moderate or severe acne subpopulations.
    Webster G; Rich P; Gold MH; Mraz S; Calvarese B; Chen D
    J Drugs Dermatol; 2009 Aug; 8(8):736-43. PubMed ID: 19663111
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tazarotene 0.045% Lotion for Females With Acne: Analysis of Two Adult Age Groups.
    Stein Gold L; Kircik L; Baldwin H; Callender V; Tanghetti E; Del Rosso J; Zeichner J; Cook-Bolden F; Guenin E
    J Drugs Dermatol; 2022 Jun; 21(6):587-595. PubMed ID: 35674760
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adapalene/Benzoyl Peroxide Gel 0.3%/2.5%: Effective Acne Therapy Regardless of Age or Gender.
    Stein Gold L; Werschler WP; Mohawk J
    J Drugs Dermatol; 2017 Jun; 16(6):582-589. PubMed ID: 28686776
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combination therapy with adapalene-benzoyl peroxide and oral lymecycline in the treatment of moderate to severe acne vulgaris: a multicentre, randomized, double-blind controlled study.
    Dréno B; Kaufmann R; Talarico S; Torres Lozada V; Rodríguez-Castellanos MA; Gómez-Flores M; De Maubeuge J; Berg M; Foley P; Sysa-Jedrzejowska A; Kerrouche N; Paliargues F; Bettoli V
    Br J Dermatol; 2011 Aug; 165(2):383-90. PubMed ID: 21495995
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.